These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6743726

  • 41. The dexamethasone suppression test in patients with alcoholism.
    Kroll P, Palmer C, Greden JF.
    Biol Psychiatry; 1983 Apr; 18(4):441-50. PubMed ID: 6860720
    [Abstract] [Full Text] [Related]

  • 42. Dexamethasone suppression test status and severity of depression.
    Meador-Woodruff JH, Greden JF, Grunhaus L, Haskett RF.
    Biol Psychiatry; 1988 Oct; 24(6):693-6. PubMed ID: 3167151
    [No Abstract] [Full Text] [Related]

  • 43. The dexamethasone suppression test, poststroke depression, and the validity of DSM-III-based diagnostic criteria.
    Ross ED, Gordon WA, Hibbard M, Egelko S.
    Am J Psychiatry; 1986 Sep; 143(9):1200-1. PubMed ID: 3752314
    [No Abstract] [Full Text] [Related]

  • 44. The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis.
    Hubain PP, Staner L, Dramaix M, Kerkhofs M, Papadimitriou G, Mendlewicz J, Linkowski P.
    Biol Psychiatry; 1998 Feb 01; 43(3):220-9. PubMed ID: 9494704
    [Abstract] [Full Text] [Related]

  • 45. Results of the dexamethasone suppression test in psychiatric patients with and without weight loss.
    Keitner GI, Brown WA, Qualls CB, Haier RJ, Barnes KT.
    Am J Psychiatry; 1985 Feb 01; 142(2):246-8. PubMed ID: 3970250
    [Abstract] [Full Text] [Related]

  • 46. DST non-suppression predicts suicide after attempted suicide.
    Jokinen J, Carlborg A, Mårtensson B, Forslund K, Nordström AL, Nordström P.
    Psychiatry Res; 2007 Apr 15; 150(3):297-303. PubMed ID: 17316825
    [Abstract] [Full Text] [Related]

  • 47. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.
    Tandon R, Silk KR, Greden JF, Goodson J, Hariharan M, Meador-Woodruff JH, Kronfol Z.
    Biol Psychiatry; 1989 Mar 15; 25(6):788-92. PubMed ID: 2629711
    [No Abstract] [Full Text] [Related]

  • 48. Cortisol suppression index: a new approach to interpreting the DST in depression.
    Bernstein JP, Chung SY, Avila KS.
    J Clin Psychiatry; 1982 Dec 15; 43(12):476-8. PubMed ID: 7161249
    [Abstract] [Full Text] [Related]

  • 49. Menstrual cycle effects on the dexamethasone suppression test in major depression.
    Tandon R, Haskett RF, Cardona D, Alcser K, Greden JF.
    Biol Psychiatry; 1991 Mar 01; 29(5):485-8. PubMed ID: 2018822
    [No Abstract] [Full Text] [Related]

  • 50. The dexamethasone suppression test as an indication of depression in patients with mental retardation.
    Mattes JA, Amsell L.
    Am J Ment Retard; 1993 Nov 01; 98(3):354-9. PubMed ID: 7904820
    [Abstract] [Full Text] [Related]

  • 51. The Dexamethasone Suppression Test in depression, in schizophrenia, and during experimental stress.
    Baumgartner A, Gräf KJ, Kürten I.
    Biol Psychiatry; 1985 Jun 01; 20(6):675-9. PubMed ID: 3995114
    [No Abstract] [Full Text] [Related]

  • 52. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW, Quitkin FM, McGrath PJ, Klein DF.
    J Affect Disord; 2005 Jun 01; 86(2-3):161-7. PubMed ID: 15935235
    [Abstract] [Full Text] [Related]

  • 53. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Weissenburger JE, Fulton CL, Fairchild CJ, Roffwarg HP.
    Biol Psychiatry; 1997 May 01; 41(9):915-28. PubMed ID: 9110097
    [Abstract] [Full Text] [Related]

  • 54. Recent research on the DST.
    Pitts FN.
    J Clin Psychiatry; 1984 Sep 01; 45(9):380-1. PubMed ID: 6469921
    [No Abstract] [Full Text] [Related]

  • 55. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 01; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 56. The dexamethasone suppression test and residual schizophrenia.
    Harris VJ.
    Am J Psychiatry; 1985 May 01; 142(5):659-60. PubMed ID: 3985211
    [No Abstract] [Full Text] [Related]

  • 57. Normalization of dexamethasone test associated with social support system improvement.
    Schwartz LS.
    Psychiatr J Univ Ott; 1984 Mar 01; 9(1):45-6. PubMed ID: 6374718
    [No Abstract] [Full Text] [Related]

  • 58. The sensitivity and specificity of the DST in child psychiatric disorders.
    Sellman D, Ney P.
    Aust N Z J Psychiatry; 1984 Sep 01; 18(3):289. PubMed ID: 6593063
    [No Abstract] [Full Text] [Related]

  • 59. Weight loss and the dexamethasone suppression test.
    Kline MD, Beeber AR.
    Arch Gen Psychiatry; 1983 Sep 01; 40(9):1034-5. PubMed ID: 6615151
    [No Abstract] [Full Text] [Related]

  • 60. Influence of weight loss on the dexamethasone suppression test.
    Berger M, Pirke KM, Doerr P, Krieg C, von Zersseen D.
    Arch Gen Psychiatry; 1983 May 01; 40(5):585-6. PubMed ID: 6838337
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.